Guy Levy - Jun 15, 2021 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Director
Signature
/s/ Guy Levy
Stock symbol
BCAB
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
6/16/2021, 09:33 PM
Next filing
Jun 21, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAB Stock Option (right to buy) Award $0 +12.3K $0.00 12.3K Jun 15, 2021 Common Stock 12.3K $39.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, subject to the Optionee continuing to provide services to the Company through the vesting date; provided however, that if the Optionee ceases to provide services to the Company prior to the vesting date for any reason other than Cause (as defined in the Plan), such Option will vest on a pro-rata basis determined by multiplying the total number of shares by a fraction, the numerator of which is the number of whole months that the Optionee provided services to the Company since the date that the award was granted, and the denominator of which is 12 months.